Acquisition Buzz Surrounds Hologic as Major Buyout Deal Emerges

The investment community is closely monitoring Hologic shares following a significant acquisition proposal. With private equity heavyweights making their move and quarterly results pending, shareholders face a complex investment landscape.

In a major market development, private equity firms Blackstone and TPG announced a binding acquisition agreement for Hologic on October 21, 2025. The transaction values the company at approximately $18.3 billion, offering shareholders up to $79 per share.

Under the agreement’s terms, investors will receive $76 per share in cash plus a non-transferable contingent value right of up to $3. This additional payment depends on Hologic achieving specific revenue targets within its breast health business segment during fiscal years 2026 and 2027. The offer price represents Read more...